FMP
H-CYTE, Inc.
HCYT
PNK
Inactive Equity
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
0.995 USD
-0.005 (-0.503%)
About
ceo
Mr. Michael W. Yurkowsky
sector
Healthcare
industry
Biotechnology
website
https://www.hcyte.com
exchange
PNK
Description
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
CIK
0001591165
ISIN
US4041241096
CUSIP
404124109
Address
2202 North West Shore Boulevar...
Phone
888 664 2983
Country
US
Employee
2
IPO Date
Dec 19, 2014
Key Executives
